Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FERRARO, Donatella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.793
EU - Europa 3.913
AS - Asia 3.678
SA - Sud America 480
AF - Africa 112
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.669
SG - Singapore 1.523
RU - Federazione Russa 1.207
CN - Cina 902
IT - Italia 758
FI - Finlandia 424
BR - Brasile 385
HK - Hong Kong 376
UA - Ucraina 296
DE - Germania 295
VN - Vietnam 282
PL - Polonia 182
FR - Francia 168
IE - Irlanda 158
GB - Regno Unito 145
JP - Giappone 121
BD - Bangladesh 93
SE - Svezia 93
IN - India 86
CA - Canada 64
KR - Corea 45
IQ - Iraq 41
BE - Belgio 35
MX - Messico 33
NL - Olanda 31
AR - Argentina 29
UZ - Uzbekistan 27
AT - Austria 26
TR - Turchia 26
RO - Romania 21
CI - Costa d'Avorio 19
ZA - Sudafrica 19
SA - Arabia Saudita 18
PK - Pakistan 16
AU - Australia 15
CO - Colombia 15
EC - Ecuador 15
ES - Italia 15
IR - Iran 15
MA - Marocco 15
VE - Venezuela 14
ID - Indonesia 13
KE - Kenya 13
PH - Filippine 12
DZ - Algeria 11
CZ - Repubblica Ceca 10
LB - Libano 9
NP - Nepal 9
JO - Giordania 8
LT - Lituania 8
TN - Tunisia 8
KG - Kirghizistan 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
CH - Svizzera 6
BG - Bulgaria 5
CL - Cile 5
EG - Egitto 5
HN - Honduras 5
JM - Giamaica 5
MY - Malesia 5
OM - Oman 5
SN - Senegal 5
AL - Albania 4
AM - Armenia 4
AZ - Azerbaigian 4
PE - Perù 4
CG - Congo 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
IL - Israele 3
KZ - Kazakistan 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 14.979
Salva come PNG Salva come JPEG
Città #
Singapore 1.115
Ashburn 890
Fairfield 714
Chandler 452
Woodbridge 389
Hong Kong 361
San Jose 356
Wilmington 292
Houston 285
Ann Arbor 275
Seattle 260
Cambridge 236
Palermo 181
Moscow 177
Zgierz 159
Dublin 157
Jacksonville 154
Beijing 143
Des Moines 137
Medford 137
Tokyo 119
Nanjing 114
Los Angeles 107
Frankfurt am Main 106
Santa Clara 96
Ho Chi Minh City 94
Altamura 88
New York 87
Hanoi 84
Princeton 83
Lauterbourg 78
Boardman 76
Dallas 73
Lawrence 63
Helsinki 58
San Diego 52
The Dalles 49
Council Bluffs 48
Hefei 46
Shenyang 43
Buffalo 42
Milan 41
Tulsa 41
Brussels 32
London 32
Dearborn 29
Nanchang 29
Orem 28
Rome 27
São Paulo 27
Changsha 26
Chicago 25
Jinan 24
Hebei 22
Ottawa 22
Tashkent 21
Jiaxing 20
Abidjan 18
Chennai 17
Phoenix 17
Zhengzhou 17
Baghdad 16
Tianjin 16
Atlanta 15
Guangzhou 15
Ludwigshafen am Rhein 15
Munich 15
Ningbo 15
Nuremberg 15
Saint Petersburg 15
Kumar 14
Rio de Janeiro 14
Warsaw 14
Columbus 13
Haiphong 13
Amsterdam 12
Hangzhou 12
Izmir 12
San Paolo di Civitate 12
Turku 12
Johannesburg 11
Montreal 11
Norwalk 11
Seongnam 11
Seoul 11
Toronto 11
Denver 10
Lappeenranta 10
Mumbai 10
Nairobi 10
Orange 10
San Francisco 10
Stockholm 10
Tehran 10
Vienna 10
Brooklyn 9
Goiânia 9
Mexico City 9
Paris 9
Salvador 9
Totale 9.457
Salva come PNG Salva come JPEG
Nome #
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 325
Hepatitis B virus reactivation and alemtuzumab therapy 311
HCV genotypes in Sicily: is there any evidence of a shift? 310
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 293
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin 287
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 278
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay 263
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 253
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 240
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 237
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 226
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance 226
Hepatitis B virus reactivation and alemtuzumab therapy 224
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. 224
Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy 223
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium 219
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model 216
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 214
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 213
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 211
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial 204
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission 202
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 200
Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients 197
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study 195
Characterization of measles virus strains circulating in Southern Italy (Palermo area, Sicily) between 2010 and 2011 194
RUOLO DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO 193
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction 188
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination 186
Genotyping of Legionella pneumophila serogroup 1 strains isolated in Northern Sicily, Italy. 185
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION 184
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) 184
Rat CNS neurons are not yet programmed to shorten their chromatin repeat length at the end of fetal neurogenesis 181
An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2 180
Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico 179
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis 178
Impact of HBV genotypes A and D genetic variability on infection evolution 177
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study 174
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir 174
HCV genotypes in western Sicily: any evidence for a shift? 173
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier 172
Triiodothyronine‐Induced Shortening of Chromatin Repeat Length in Neurons Cultured in a Chemically Denned Medium 171
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 170
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? 169
Inhibition of glial proliferation in vitro by serum from patients with multiple sclerosis 168
Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination 166
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors 164
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS 163
Bayesian coalescent inference of hepatitis C virus introduction from molecular sequences: the Camporeale model 162
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) 162
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT 162
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano 161
Infezione occulta da HBV in pazienti con malattie oncoematologiche 158
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale 156
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. 153
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 153
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT 148
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 146
IL-10 and TNF-α polymorphisms and the recovery from HCV infection 143
LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION 143
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 142
Triiodothyronine accelerates the synthesis of Synapsin I in developing neurons from fetal rat brain cultured in a synthetic medium 141
Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) 139
Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy 139
Evaluation of the diagnostic performances of two commercially available assays for the detection of enteric adenovirus antigens 138
Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition 136
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 133
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV 128
RIATTIVAZIONE DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITÀ VIRALE 123
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 123
Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale 121
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC 120
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? 120
High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C 119
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 119
Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization 114
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin 112
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE 111
INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITA’ VIRALE 109
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 109
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 108
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients 107
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study 101
Do not forget mpox! 100
Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France 94
Atypical case of monkeypox with multiple bacterial skin superinfection 90
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 88
Post-COVID-19 Epidemiology of Viral Infections in Adults Hospitalized with Acute Respiratory Syndromes in Palermo, South of Italy 79
Liver follicular helper T-cells in chronic hepatitis C 74
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 72
SARS-CoV-2 infection during pregnancy and necrotizing enterocolitis: case report and review of the literature 50
Neutralizing Antibody Response to SARS-CoV-2 Variants After Two mRNA COVID-19 Vaccine Doses in a Cohort of Patients with Inflammatory Bowel Disease from a Southern Italy Tertiary Hospital 42
Multiple nodules and pustules in a traveler 40
From marine neglected substrata new fungal taxa of potential biotechnological interest: the case of Pelagia noctiluca 8
Tamaricicola fenicei sp. nov. (Pleosporaceae, Pleosporales), a New Marine Fungus with Significant Antiviral Activity 8
Totale 15.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.461
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 0 116
2021/2022949 36 204 45 36 24 34 40 51 113 131 53 182
2022/20231.362 129 286 23 126 148 217 95 85 141 9 65 38
2023/2024561 35 65 44 71 61 114 37 23 14 16 10 71
2024/20251.646 26 97 56 156 58 62 129 109 136 202 238 377
2025/20266.141 445 181 287 414 583 991 879 703 478 857 288 35
Totale 15.468